77 Combination of radiotherapy and chemotherapy is advisable in all patients with clinical stage I–II Hodgkin's disease six-year results of the EORTC-GPMC controlled clinical trials ‘H7-VF’, ‘H7-F’ and ‘H7-U’
暂无分享,去创建一个
A. Hagenbeek | E. Noordijk | U. Tirelli | M. Henry-Amar | A. Mandard | H. Eghbali | P. Carde | J. Kluin-Nelemans | J. Thomas | N. Dupouy | J. Burgers | M. Monconduit